Evidence map›Paper›PMID 38203648›Full record

ArticleInternational journal of molecular sciences2023

Liseth Rubi Aldaba-Muruato, Sandra Sánchez-Barbosa, Víctor Hugo Rodríguez-Purata, Georgina Cabrera-Cruz, Estefany Rosales-Domínguez, Daniela Martínez-Valentín, Yoshio Aldo Alarcón-López, Pablo Aguirre-Vidal, Manuel Alejandro Hernández-Serda, Luis Alfonso Cárdenas-Granados and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Liseth Rubi Aldaba-MuruatoBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.
Sandra Sánchez-BarbosaBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.
Víctor Hugo Rodríguez-PurataPharmacobiological Sciences, Faculty of Chemical Sciences, Autonomous University of San Luis Potosi, San Luis Potosi 78210, Mexico.
Georgina Cabrera-CruzBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.
Estefany Rosales-DomínguezBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.
Daniela Martínez-ValentínBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.
Yoshio Aldo Alarcón-LópezLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.
Pablo Aguirre-VidalLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.
Manuel Alejandro Hernández-SerdaLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.ORCID 0009-0009-0702-1502
Luis Alfonso Cárdenas-GranadosLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.ORCID 0009-0004-8687-4143
Víctor Hugo Vázquez-ValadezLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.
Enrique AngelesLaboratorio de Química Teórica y Medicinal, FESC, Universidad Nacional Autónoma de México, Avenida 1 de Mayo S/N, Santa María las Torre, Cuautitlán Izcalli 54750, Estado de México, Mexico.ORCID 0000-0003-0068-322X
José Roberto Macías-PérezBiomedical Science Laboratory, Clinical Chemistry, Faculty of Professional Studies Huasteca Zone, Autonomous University of San Luis Potosi, Ciudad Valles 79060, San Luis Potosi, Mexico.ORCID 0000-0001-7925-2494
Autonomous University of San Luis Potosí · MXUniversidad de Cuautitlán Izcalli · MX

Funding

Consejo Nacional de Humanidades, Ciencias y Tecnologías 320331UNAM PAPIIT IN206023, PIAPI2005, de la SRE de México and LANCAD-UNAM-DGTIC-034 Grupo de Trabajo XVIII GTMQ
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

HydroquinonesNF-E2-Related Factor 2AnimalsKelch-Like ECH-Associated Protein 1Molecular Docking SimulationNecrosisRatsRats, Wistar2-tert-butylhydroquinoneHydroquinonesKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2acute liver damagecholestasisin silico studiesmortalitynecrosissurvival

Identifiers

PMID38203648
PMCPMC10779046
OpenAlexW4390398414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.